OTCQB
PLSH

Panacea Life Sciences Holdings Inc

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

Panacea Life Sciences Holdings Inc Stock Price

Vitals

Today's Low:
$0.3625
Today's High:
$0.4
Open Price:
$0.4
52W Low:
$0.0421
52W High:
$0.625
Prev. Close:
$0.4
Volume:
1901

Company Statistics

Market Cap.:
$3.84 million
Book Value:
-0.143
Revenue TTM:
$1.84 million
Operating Margin TTM:
0%
Gross Profit TTM:
$-4418481
Profit Margin:
0%
Return on Assets TTM:
-16.15%
Return on Equity TTM:
-4290.85%

Company Profile

Panacea Life Sciences Holdings Inc had its IPO on under the ticker symbol PLSH.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Panacea Life Sciences Holdings Inc has a staff strength of 19 employees.

Stock update

Shares of Panacea Life Sciences Holdings Inc opened at $0.4 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.36 - $0.4, and closed at $0.36.

This is a -9.38% slip from the previous day's closing price.

A total volume of 1,901 shares were traded at the close of the day’s session.

In the last one week, shares of Panacea Life Sciences Holdings Inc have increased by +9.85%.

Panacea Life Sciences Holdings Inc's Key Ratios

Panacea Life Sciences Holdings Inc has a market cap of $3.84 million, indicating a price to book ratio of 0.4649 and a price to sales ratio of 0.5477.

In the last 12-months Panacea Life Sciences Holdings Inc’s revenue was $1.84 million with a gross profit of $-4418481 and an EBITDA of $-3564617. The EBITDA ratio measures Panacea Life Sciences Holdings Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Panacea Life Sciences Holdings Inc’s operating margin was 0% while its return on assets stood at -16.15% with a return of equity of -4290.85%.

In Q1, Panacea Life Sciences Holdings Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 45.2%.

Panacea Life Sciences Holdings Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-0.58 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Panacea Life Sciences Holdings Inc’s profitability.

Panacea Life Sciences Holdings Inc stock is trading at a EV to sales ratio of 9.2568 and a EV to EBITDA ratio of -2.728. Its price to sales ratio in the trailing 12-months stood at 0.5477.

Panacea Life Sciences Holdings Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$18.56 million
Total Liabilities
$15.89 million
Operating Cash Flow
$0
Capital Expenditure
$15220
Dividend Payout Ratio
0%

Panacea Life Sciences Holdings Inc ended 2024 with $18.56 million in total assets and $0 in total liabilities. Its intangible assets were valued at $18.56 million while shareholder equity stood at $-3800839.00.

Panacea Life Sciences Holdings Inc ended 2024 with $0 in deferred long-term liabilities, $15.89 million in other current liabilities, in common stock, $-27698892.00 in retained earnings and $2.19 million in goodwill. Its cash balance stood at $73232.00 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $3.57 million.

Panacea Life Sciences Holdings Inc’s total current assets stands at $5.95 million while long-term investments were $0 and short-term investments were $925107.00. Its net receivables were $274787.00 compared to accounts payable of $0 and inventory worth $4.10 million.

In 2024, Panacea Life Sciences Holdings Inc's operating cash flow was $0 while its capital expenditure stood at $15220.

Comparatively, Panacea Life Sciences Holdings Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.36
52-Week High
$0.625
52-Week Low
$0.0421
Analyst Target Price
$

Panacea Life Sciences Holdings Inc stock is currently trading at $0.36 per share. It touched a 52-week high of $0.625 and a 52-week low of $0.625. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.44 and 200-day moving average was $0.24 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Panacea Life Sciences Holdings Inc

The stock symbol (also called stock or share ticker) of Panacea Life Sciences Holdings Inc is PLSH

The IPO of Panacea Life Sciences Holdings Inc took place on

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
Domo Inc (DOMO)
$10.49
-0.15
-1.41%
$7.12
0.14
+2.01%
$1.8
-0.18
-9.09%
$24.39
0.42
+1.75%
$0.7
-0.03
-3.95%
$38.45
-2.02
-4.99%
$3683.2
-102.4
-2.71%
$21.41
0.08
+0.38%
$63.97
-1.3
-1.99%
$11.49
0.45
+4.08%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Panacea Life Sciences Holdings, Inc., operates as a holding company, manufactures, research, and produces hemp-derived cannabinoid, functional mushroom, kratom, and nutraceutical products for consumers and pets. The company also involved in the white label and contract manufacturing sales to other cannabinoid companies, raw material sales, and tolling arrangements. In addition, it offers natural remedies for aspect of life under the PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure, and PANA Life brand name. The company was incorporated in 2008 and is headquartered in Greenwood Village, Colorado.

Address

5910 South University Boulevard, Greenwood Village, CO, United States, 80121